Yuan Defu, Li Mingma, Zhou Ying, Shi Lingen, Lu Jing, Fu Gengfeng, Wang Bei
Department of Epidemiology and Health Statistics, Key Laboratory of Environmental Medicine Engineering of Ministry of Education, School of Public Health, Southeast University, Nanjing, China.
Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, China.
J Virus Erad. 2023 Mar 4;9(1):100320. doi: 10.1016/j.jve.2023.100320. eCollection 2023 Mar.
Antiretroviral therapy (ART) aims to inhibit HIV replication, decrease CD4 T cell loss, and immune function recovery in order to reduce the morbidity and mortality associated with the infection. Treatment should also, improve quality of life and control HIV spread. However, incomplete viral suppression still occurs during ART. Viral suppression and virological failure (VF) thresholds vary between studies in terms of virological rebound (VR) states using different detection thresholds. Further understanding of influencing factors and adverse outcomes in various VR states should provide important guidance for HIV treatment.
抗逆转录病毒疗法（ART）旨在抑制HIV复制，减少CD4 T细胞损失，并恢复免疫功能，以降低与该感染相关的发病率和死亡率。治疗还应改善生活质量并控制HIV传播。然而，在ART期间仍会出现病毒抑制不完全的情况。在使用不同检测阈值的病毒学反弹（VR）状态方面，不同研究的病毒抑制和病毒学失败（VF）阈值有所不同。进一步了解各种VR状态下的影响因素和不良后果应为HIV治疗提供重要指导。
